Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–56.

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–726.

Article  CAS  PubMed  Google Scholar 

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272–87.

Article  CAS  Google Scholar 

Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol. 2017;1(236):283–9.

Article  Google Scholar 

Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P, et al. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8(2):1007–17.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Yuan M, Gong M, Tse G, Li G, Liu T. Frailty and clinical outcomes in heart failure: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018;19(11):1003-1008.e1.

Article  PubMed  Google Scholar 

Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. Eur J Prev Cardiol. 2020 Nov 22;(zwaa117). https://doi.org/10.1093/eurjpc/zwaa117. Cited 2021 Jul 20.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-156.

Article  CAS  PubMed  Google Scholar 

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

Article  PubMed  Google Scholar 

Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, et al. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction. ESC Heart Fail. 2022;9(3):1853–63.

Article  PubMed  PubMed Central  Google Scholar 

Chandrashekhar Iyer L, Vaishali K, Babu AS. Prevalence of sarcopenia in heart failure: a systematic review. Indian Heart J. 2023;75(1):36–42.

Article  PubMed  Google Scholar 

Beltrami M, Fumagalli C, Milli M. Frailty, sarcopenia and cachexia in heart failure patients: different clinical entities of the same painting. World J Cardiol. 2021;13(1):1–10.

Article  PubMed  PubMed Central  Google Scholar 

Kinugasa Y, Yamamoto K. The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction. Heart. 2017;103(3):184–9.

Article  CAS  PubMed  Google Scholar 

Pazan F, Petrovic M, Cherubini A, Onder G, Cruz-Jentoft AJ, Denkinger M, et al. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. Eur J Clin Pharmacol. 2021;77(1):1–12.

Article  CAS  PubMed  Google Scholar 

Palmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, Curtin D, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10(1):9–36.

Article  PubMed  Google Scholar 

Yin J, Lu X, Qian Z, Xu W, Zhou X. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019;9(14):4019–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mellen RH, Girotto OS, Marques EB, Laurindo LF, Grippa PC, Mendes CG, et al. Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines. 2023;11(1):136.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabral J, Vasconcelos H, Maia-Araújo P, Moreira E, Campelo M, Amorim S, et al. Sacubitril/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic. Cardiovasc Diagn Ther. 2021;11(6):1217–27.

Article  PubMed  PubMed Central  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635569/. Cited 2020 Dec 9.

Valdiviesso R, Azevedo LF, Moreira E, Ataíde R, Martins S, Fernandes L, et al. Frailty phenotype and associated nutritional factors in a sample of Portuguese outpatients with heart failure. Nutr Metab Cardiovasc Dis NMCD. 2021;31(8):2391–7.

Article  PubMed  Google Scholar 

Schectman O, Sindhu B. Grip Strenght. In: Clinical Assessment Recommendations. American Society of Hand Therapists; 2015.

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9(12):e113637.

Article  PubMed  PubMed Central  Google Scholar 

Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31(5):652–8.

Article  PubMed  Google Scholar 

Landi F, Onder G, Russo A, Liperoti R, Tosato M, Martone AM, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr Edinb Scotl. 2014;33(3):539–44.

Article  Google Scholar 

Sousa-Santos AR, Afonso C, Borges N, Santos A, Padrão P, Moreira P, et al. Sarcopenia, physical frailty, undernutrition and obesity cooccurrence among Portuguese community-dwelling older adults: results from Nutrition UP 65 cross-sectional study. BMJ Open. 2020;10(6):e033661.

Article  PubMed  PubMed Central  Google Scholar 

Rasheedy D, EL-Kawaly WH. The cumulative impact of sarcopenia, frailty, malnutrition, and cachexia on other geriatric syndromes in hospitalized elderly. Electron J Gen Med. 2021;18(2):em277.

Article  Google Scholar 

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23.

Article  PubMed  PubMed Central  Google Scholar 

Ibrahim K, Howson FFA, Culliford DJ, Sayer AA, Roberts HC. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools. BMC Geriatr. 2019;19(1):42.

Article  PubMed  PubMed Central  Google Scholar 

Gingrich A, Volkert D, Kiesswetter E, Thomanek M, Bach S, Sieber CC, et al. Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr. 2019;19(1):120.

Article  PubMed  PubMed Central  Google Scholar 

Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2017;36:78–87.

Article  PubMed  Google Scholar 

Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(2):385–401.

Article  Google Scholar 

Wang H, Hai S, Liu Y, Cao L, Liu Y, Liu P, et al. Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging. 2018;5(13):1605–11.

Article  Google Scholar 

Yuenyongchaiwat K, Boonsinsukh R. Sarcopenia and its relationships with depression, cognition, and physical activity in thai community-dwelling older adults. Curr Gerontol Geriatr Res. 2020;23(2020):e8041489.

Google Scholar 

Chen L, Sheng Y, Qi H, Tang T, Yu J, Lv S. Correlation of sarcopenia and depressive mood in older community dwellers: a cross-sectional observational study in China. BMJ Open. 2020;10(9):e038089.

Article  PubMed  PubMed Central  Google Scholar 

Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing. 2019;48(2):196–203.

Article  PubMed  Google Scholar 

Hori H, Fukuchi T, Sugawara H. Anticoagulant therapy for frail patients with atrial fibrillation. Intern Med. 2021;60(4):495–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oqab Z, Pournazari P, Sheldon RS. What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis. J Atr Fibrillation. 2018;10(6):1870.

Article  PubMed  PubMed Central  Google Scholar 

Valdiviesso R, Sousa-Santos AR, Azevedo LF, Moreira E, Amaral TF, Silva-Cardoso J, et al. Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study. BMC Cardiovasc Disord. 2022;22(1):356.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Picca A, Coelho-Junior HJ, Calvani R, Marzetti E, Vetrano DL. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530.

Article  CAS  PubMed  Google Scholar 

Yin J, Qian Z, Chen Y, Li Y, Zhou X. MicroRNA regulatory networks in the pathogenesis of sarcopenia. J Cell Mol Med. 2020;24(9):4900–12.

Article  CAS 

留言 (0)

沒有登入
gif